Advertisement
In a research letter published online April 30 in the New England Journal of Medicine

Transplanting HCV+ Kidneys Into HCV− Recipients Feasible

0
Doctors say they can clear hepatitis C in organ recipients, perhaps shortening transplant waits
Hackers are increasingly targeting hospitals

Hospitals Need to Be Prepared for Ransomware Attacks

0
Medical information a vulnerable target for those planning ransomware attacks, doctor warns
An underlying mechanism has been identified that could eventually lead to the first drug therapy for lymphedema

Leukotriene B4 Is Promising Drug Target for Tx of Lymphedema

0
Ketoprofen prevents tissue injury, fluid build-up by blocking leukotriene B4, researchers say
Taking medication for attention-deficit/hyperactivity disorder (ADHD) is tied to lower odds of car accidents involving patients with ADHD

ADHD Meds Associated With Reduced Risk for Car Crashes

0
Symptoms such as inattention, impulsivity raise accident risk, researchers say
Young adults with HIV who get treatment are living longer in North America and Europe

Life Expectancy for HIV+ Patients Up Since Introduction of ART

0
Physicians need to focus on encouraging patients to take their drugs consistently
From 2001 to 2010

Postmarket Safety Events for 32 Percent of Novel Therapeutics

0
Thirty-two percent of 222 FDA approved novel therapeutics from 2001 to 2010 were affected
For patients with type 2 diabetes and vitamin D deficiency

Vitamin D Doesn’t Impact Insulin Sensitivity, Secretion in T2DM

0
No difference between or within groups in insulin sensitivity, glycemic control with vitamin D3, placebo
Nonsteroidal anti-inflammatory drugs increase the risk of acute myocardial infarction by 20 to 50 percent

Initiation of NSAID Use Associated With Risk of Acute MI

0
Risk greatest during first month of NSAID use and with higher doses
The addition of selumetinib to docetaxel does not improve progression-free survival among patients with previously treated advanced KRAS-mutant non-small-cell lung cancer

Adding Selumetinib to Docetaxel Doesn’t Up PFS in NSCLC

0
No improvement in progression-free survival for previously treated advanced KRAS-mutant NSCLC
Low-dose aspirin does not protect against cognitive decline

Low-Dose Aspirin No Aid Against Cognitive Decline

0
Review of large studies found no protection against dementia